European Journal of Chemistry 2021, 12(3), 323-328 | doi: https://doi.org/10.5155/eurjchem.12.3.323-328.2134 | Get rights and content

Issue cover




Crossmark

  Open Access OPEN ACCESS | Open Access PEER-REVIEWED | RESEARCH ARTICLE | DOWNLOAD PDF | VIEW FULL-TEXT PDF | TOTAL VIEWS

Pharmaceutical organic salt: Disordered crystal structure of levofloxacin with γ-resorcylic acid


Syed Muddassir Ali Mashhadi (1,*) orcid , Muhammad Nawaz Tahir (2) orcid , David Apperley (3) orcid , Moazzam Hussain Bhatti (4) orcid , Muhammad Ashfaq (5) orcid , Uzma Yunus (6) orcid

(1) Department of Chemistry, University of Agriculture Faisalabad (Depalpur Okara Campus), Okara, 56130, Pakistan
(2) Department of Physics, University of Sargodha, Sargodha, 40100, Pakistan
(3) Department of Chemistry, Durham University, Stockton Road, Durham, DH1 3LE, United Kingdom
(4) Department of Chemistry, Allama Iqbal Open University, Islamabad, 44310, Pakistan
(5) Department of Physics, University of Sargodha, Sargodha, 40100, Pakistan
(6) Department of Chemistry, Allama Iqbal Open University, Islamabad, 44310, Pakistan
(*) Corresponding Author

Received: 06 Jul 2021 | Revised: 02 Aug 2021 | Accepted: 08 Aug 2021 | Published: 30 Sep 2021 | Issue Date: September 2021

Abstract


This study reports an organic salt prepared from an antibacterial drug, levofloxacin and antioxidant γ-resorcylic acid. A simple preparation method leads to a crystal with disordered structure. The idea is to prepare an organic salt comprising of pharmaceutically acceptable acidic and basic components. The salt is characterised by IR, solid state NMR, and single crystal XRD. Crystal data for C25H26N3O8F: triclinic, space group P-1 (no. 2), a = 7.0037(8) Å, b = 12.764(3) Å, c = 13.909(3) Å, α = 104.821(4)°, β = 92.039(4)°, γ = 95.334(4)°, = 1194.6(4) Å3, Z = 2, T = 296(2) K, μ(MoKα) = 0.113 mm-1, Dcalc = 1.433 g/cm3, 16879 reflections measured (5.048° ≤ 2Θ ≤ 54.186°), 5139 unique (Rint = 0.0663, Rsigma = 0.0975) which were used in all calculations. The final R1 was 0.1121 (I>2σ(I)) and wR2 was 0.2505 (all data). SC-XRD analysis shows that the crystal packing is stabilized by strong H-bonding of type N-H···O and comparatively weak interactions of type C-H···O, C-H···π and off-set π···π stacking.


Announcements


One of our sponsors will cover the article processing fee for all submissions made between May 17, 2023 and May 31, 2023 (Voucher code: SPONSOR2023).

Editor-in-Chief
European Journal of Chemistry

Keywords


SC-XRD; SS-NM;R Organic salt; Levofloxacin; γ-Resorcylic acid; Disordered crystal structure

Full Text:

PDF
PDF    Open Access

DOI: 10.5155/eurjchem.12.3.323-328.2134

Links for Article


| | | | | | |

| | | | | | |

| | | |

Related Articles




Article Metrics

icon graph This Abstract was viewed 548 times | icon graph PDF Article downloaded 145 times


Citations

/


[1]. S. Dinagaran, J. Gajendiran, S. Gokul Raj, S. Gnanam
Growth, physico-chemical properties, opto-electrical characteristics, thermo-mechanical and DFT studies of 4-aminoantipyrine single crystals
Journal of Molecular Structure  1271, 134084, 2023
DOI: 10.1016/j.molstruc.2022.134084
/


[2]. T L Annusha, A S Jebamalar, N S Nirmala Jothi, A Jeya Rajendran, S Vigneswari, T C Sabari Girisun
Growth parameters and investigations on the structural, optical, mechanical, thermal and electrical properties of an l-proline guanidine carbonate single crystal
Journal of Molecular Structure  1282, 135155, 2023
DOI: 10.1016/j.molstruc.2023.135155
/


References


[1]. Mashhadi, S. M. A.; Yunus, U.; Bhatti, M. H.; Ahmed, I.; Tahir, M. N. J. Mol. Struct. 2016, 1117, 17-21.
https://doi.org/10.1016/j.molstruc.2016.03.057

[2]. Mashhadi, S. M. A.; Yunus, U.; Bhatti, M. H. J. Mol. Struct. 2021, 1233 (130015), 130015.
https://doi.org/10.1016/j.molstruc.2021.130015

[3]. Mashhadi, S. M. A.; Yunus, U.; Bhatti, M. H.; Tahir, M. N. J. Mol. Struct. 2014, 1076, 446-452.
https://doi.org/10.1016/j.molstruc.2014.07.070

[4]. Mashhadi, S. M. A.; Batsanov, A. S.; Sajjad, S. A.; Nazir, Y.; Bhatti, M. H.; Yunus, U. J. Mol. Struct. 2021, 1226 (129388), 129388.
https://doi.org/10.1016/j.molstruc.2020.129388

[5]. Mashhadi, S. M. A.; Yufit, D.; Liu, H.; Hodgkinson, P.; Yunus, U. J. Mol. Struct. 2020, 1219 (128621), 128621.
https://doi.org/10.1016/j.molstruc.2020.128621

[6]. Lehn, J.-M. Science 2002, 295 (5564), 2400-2403.
https://doi.org/10.1126/science.1071063

[7]. Cram, D. J. Angew. Chem. Int. Ed. Engl. 1988, 27 (8), 1009-1020.
https://doi.org/10.1002/anie.198810093

[8]. Cram, D. J.; Cram, J. M. Acc. Chem. Res. 1978, 11 (1), 8-14.
https://doi.org/10.1021/ar50121a002

[9]. Carvalho, P. S.; Diniz, L. F.; Tenorio, J. C.; Souza, M. S.; Franco, C. H. J.; Rial, R. C.; Warszawski de Oliveira, K. R.; Nazario, C. E. D.; Ellena, J. CrystEngComm 2019, 21 (24), 3668-3678.
https://doi.org/10.1039/C8CE02076K

[10]. Odiase, I.; Nicholson, C. E.; Ahmad, R.; Cooper, J.; Yufit, D. S.; Cooper, S. J. Acta Crystallogr. C Struct. Chem. 2015, 71 (Pt 4), 276-283.
https://doi.org/10.1107/S2053229615004283

[11]. Tasso, L.; de Andrade, C.; Dalla Costa, T. Int. J. Antimicrob. Agents 2011, 38 (4), 307-313.
https://doi.org/10.1016/j.ijantimicag.2011.05.015

[12]. Fish, D. N.; Chow, A. T. Clin. Pharmacokinet. 1997, 32 (2), 101-119.
https://doi.org/10.2165/00003088-199732020-00002

[13]. Blázquez Garrido, R. M.; Espinosa Parra, F. J.; Alemany Francés, L.; Ramos Guevara, R. M.; Sánchez-Nieto, J. M.; Segovia Hernández, M.; Serrano Martínez, J. A.; Huerta, F. H. Clin. Infect. Dis. 2005, 40 (6), 800-806.
https://doi.org/10.1086/428049

[14]. Gdaniec, M.; Gilski, M.; Denisov, G. S. Acta Crystallogr. C 1994, 50 (10), 1622-1626.
https://doi.org/10.1107/S0108270194000557

[15]. Bandari, S.; Dronam, V. R.; Eedara, B. B. J. Pharm. Investig. 2017, 47 (6), 583-591.
https://doi.org/10.1007/s40005-016-0302-8


Supporting information


The Supplementary Material for this article can be found online at: Supplementary files

How to cite


Mashhadi, S.; Tahir, M.; Apperley, D.; Bhatti, M.; Ashfaq, M.; Yunus, U. Eur. J. Chem. 2021, 12(3), 323-328. doi:10.5155/eurjchem.12.3.323-328.2134
Mashhadi, S.; Tahir, M.; Apperley, D.; Bhatti, M.; Ashfaq, M.; Yunus, U. Pharmaceutical organic salt: Disordered crystal structure of levofloxacin with γ-resorcylic acid. Eur. J. Chem. 2021, 12(3), 323-328. doi:10.5155/eurjchem.12.3.323-328.2134
Mashhadi, S., Tahir, M., Apperley, D., Bhatti, M., Ashfaq, M., & Yunus, U. (2021). Pharmaceutical organic salt: Disordered crystal structure of levofloxacin with γ-resorcylic acid. European Journal of Chemistry, 12(3), 323-328. doi:10.5155/eurjchem.12.3.323-328.2134
Mashhadi, Syed, Muhammad Nawaz Tahir, David Apperley, Moazzam Hussain Bhatti, Muhammad Ashfaq, & Uzma Yunus. "Pharmaceutical organic salt: Disordered crystal structure of levofloxacin with γ-resorcylic acid." European Journal of Chemistry [Online], 12.3 (2021): 323-328. Web. 29 May. 2023
Mashhadi, Syed, Tahir, Muhammad, Apperley, David, Bhatti, Moazzam, Ashfaq, Muhammad, AND Yunus, Uzma. "Pharmaceutical organic salt: Disordered crystal structure of levofloxacin with γ-resorcylic acid" European Journal of Chemistry [Online], Volume 12 Number 3 (30 September 2021)

The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item



DOI Link: https://doi.org/10.5155/eurjchem.12.3.323-328.2134


CrossRef | Scilit | GrowKudos | Researchgate | Publons | ScienceGate | Scite | Lens | OUCI

WorldCat Paperbuzz | LibKey Citeas | Dimensions | Semanticscholar | Plumx | Kopernio | Zotero | Mendeley

ZoteroSave to Zotero MendeleySave to Mendeley



European Journal of Chemistry 2021, 12(3), 323-328 | doi: https://doi.org/10.5155/eurjchem.12.3.323-328.2134 | Get rights and content

Refbacks

  • There are currently no refbacks.




Copyright (c) 2021 Authors

Creative Commons License
This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at http://www.eurjchem.com/index.php/eurjchem/pages/view/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (http://www.eurjchem.com/index.php/eurjchem/pages/view/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).



© Copyright 2010 - 2023  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.